awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38213037-10566A69-CCAD-4C54-B51C-03E0B449EC0C
Q38213037-10566A69-CCAD-4C54-B51C-03E0B449EC0C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38213037-10566A69-CCAD-4C54-B51C-03E0B449EC0C
Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure.
P2860
Q38213037-10566A69-CCAD-4C54-B51C-03E0B449EC0C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38213037-10566A69-CCAD-4C54-B51C-03E0B449EC0C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
12503df0333d7c957a0252dfe50a53ec81f9b0e6
P2860
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study